U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT07506616) titled 'Membrane Potential Mapping with18F-TPP' on March 26.
Brief Summary: In this study, investigators propose to use PET imaging to study the pharmacokinetics of 18F-TPP and develop methods for imaging membrane potential (ΔΨT) in humans.
Study Start Date: April 16
Study Type: INTERVENTIONAL
Condition:
Membrane Potential Mapping
Intervention:
DRUG: 18F-TPP
radiotracer specific for imaging mitochondrial membrane potential (ΔΨm) administered intravenously
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Yale University
Information provided by (Responsible Party): Georges El Fakhri, Yale University
Published by ...